Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms

被引：1
|
作者：
Cossins, J. [1 ]
Lashley, D. [1 ]
Spearman, H. [1 ]
Maxwell, S. [1 ]
Palace, J. [2 ]
Robb, S. [3 ]
Beeson, D. [1 ]
机构：
[1] Univ Oxford, Neurosci Grp, Weatherall Inst Mol Med, Oxford OX1 2JD, England
[2] John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England
[3] Great Ormond St Hosp Sick Children, Dubowitz Neuromuscular Ctr, Inst Child Hlth, London, England
来源：
NEUROMUSCULAR DISORDERS | 2010年 / 20卷
关键词：
D O I：
10.1016/S0960-8966(10)70066-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [1] Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7
    Lashley, D.
    Palace, J.
    Jayawant, S.
    Robb, S.
    Beeson, D.
    NEUROLOGY, 2010, 74 (19) : 1517 - 1523
  • [2] Therapeutic effects of ephedrine in congenital myasthenic syndrome due to DOK7 mutations
    Schara, U.
    Deschauer, M.
    Wendt, M.
    Strigi-Pill, N.
    Mueller, J.
    Abicht, A.
    Lochmueller, H.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 818 - 819
  • [3] Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations
    Schara, U.
    Barisic, N.
    Deschauer, M.
    Lindberg, C.
    Straub, V.
    Strigl-Pill, N.
    Wendt, M.
    Abicht, A.
    Mueller, J. S.
    Lochmueller, H.
    NEUROMUSCULAR DISORDERS, 2009, 19 (12) : 828 - 832
  • [4] DOK7 congenital myasthenic syndrome
    Palace, Jacqueline
    MYASTHENIA GRAVIS AND RELATED DISORDERS II, 2012, 1275 : 49 - 53
  • [5] Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children
    Tsao, Chang-Yong
    PEDIATRIC NEUROLOGY, 2016, 54 : 85 - 87
  • [6] Variable phenotypes associated with mutations in DOK7
    Anderson, Jennifer A.
    Ng, Jarae J.
    Bowe, Constance
    McDonald, Craig
    Richman, David P.
    Wollmann, Robert L.
    Maselli, Ricardo A.
    MUSCLE & NERVE, 2008, 37 (04) : 448 - 456
  • [7] Mutations causing DOK7 congenital myasthenia ablate functional motifs in dok-7
    Hamuro, Johko
    Higuchi, Osamu
    Okada, Kumiko
    Ueno, Makiko
    Iemura, Shun-Ichiro
    Natsume, Tohru
    Spearman, Hayley
    Beeson, David
    Yamanashi, Yuji
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (09) : 5518 - 5524
  • [8] Measuring motor function response to treatment in DOK7 congenital myasthenic syndrome
    Kennedy, R.
    Ryan, M.
    de Valle, K.
    Carroll, K.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S205 - S205
  • [9] Late presentation DOK7 congenital myasthenia syndrome (CMS), misdiagnosed as myasthenia gravis (MG)- a case series
    Henehan, L.
    Rossini, E.
    Dong, Y.
    Beeson, D.
    Ramdas, S.
    Leite, I.
    Palace, J.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [10] Clinical features of the DOK7 neuromuscular junction synaptopathy
    Palace, Jacqueline
    Lashley, Daniel
    Newsom-Davis, John
    Cossins, Judy
    Maxwell, Susan
    Kennett, Robin
    Jayawant, Sandeep
    Yamanashi, Yuji
    Beeson, David
    BRAIN, 2007, 130 : 1507 - 1515
12345